Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Activation of STAT3-mediated ciliated cell survival protects against severe infection by respiratory syncytial virus
Caiqi Zhao, … , Paul H. Lerou, Xingbin Ai
Caiqi Zhao, … , Paul H. Lerou, Xingbin Ai
Published November 1, 2024
Citation Information: J Clin Invest. 2024;134(21):e183978. https://doi.org/10.1172/JCI183978.
View: Text | PDF
Research Article Infectious disease

Activation of STAT3-mediated ciliated cell survival protects against severe infection by respiratory syncytial virus

  • Text
  • PDF
Abstract

Respiratory syncytial virus (RSV) selectively targets ciliated cells in human bronchial epithelium and can cause bronchiolitis and pneumonia, mostly in infants. To identify molecular targets of intervention during RSV infection in infants, we investigated how age regulates RSV interaction with the bronchial epithelium barrier. Employing precision-cut lung slices and air-liquid interface cultures generated from infant and adult human donors, we found robust RSV virus spread and extensive apoptotic cell death only in infant bronchial epithelium. In contrast, adult bronchial epithelium showed no barrier damage and limited RSV infection. Single nuclear RNA-Seq revealed age-related insufficiency of an antiapoptotic STAT3 activation response to RSV infection in infant ciliated cells, which was exploited to facilitate virus spread via the extruded apoptotic ciliated cells carrying RSV. Activation of STAT3 and blockade of apoptosis rendered protection against severe RSV infection in infant bronchial epithelium. Lastly, apoptotic inhibitor treatment of a neonatal mouse model of RSV infection mitigated infection and inflammation in the lung. Taken together, our findings identify a STAT3-mediated antiapoptosis pathway as a target to battle severe RSV disease in infants.

Authors

Caiqi Zhao, Yan Bai, Wei Wang, Gaurang M. Amonkar, Hongmei Mou, Judith Olejnik, Adam J. Hume, Elke Mühlberger, Nicholas W. Lukacs, Rachel Fearns, Paul H. Lerou, Xingbin Ai

×

Figure 1

Human bronchial epithelium models generated from hPCLSs and TA BSCs of neonates and adults show age-related RSV infection.

Options: View larger image (or click on image) Download as PowerPoint
Human bronchial epithelium models generated from hPCLSs and TA BSCs of n...
(A) Schematic of RSV A2 or RSV-GFP infection (1 × 106 pfu) of hPCLSs prepared from donor lungs of infants and adults (n = 3 donors) followed by staining and confocal imaging at 2 dpi. (B) Representative images of RSV-GFP (green) and RFX3 (red) staining in infant hPCLSs. Left panel shows an RSV infected airway on hPCLS. Arrow indicates an airway infected by RSV. Dotted lines mark basement membrane. Blue color is nucleus staining and the overlay of red, green, and blue shows as pink color. (C) Representative images of RSV F (green) and RFX3 (red) staining in infant and adult hPCLSs. Arrows indicate RSV-infected cells. Dotted lines mark basement membrane. Blue color is nucleus staining and the overlay of red, green, and blue shows as pink color. (D) Schematic of RSV infection of differentiated bronchial epithelium in day 21 (D21) ALI cultures of neonatal and adult TA BSCs. RSV strain A2 was applied apically (MOI 2, 4 × 105 PFU) for 1 hour. Assays (E–J) were performed at 2 and 4 dpi. (E) Representative cross-section images of antibody staining for major bronchial epithelial cell types prior to infection. Blue color is nucleus staining and the overlay of red, green, and blue shows as pink color. (F) Representative top views of double staining for RSV F(green) protein and ZO1 (red). (G) Relative abundances of RSV F+ cells and relative levels of RSV L gene by RT-qPCR. (H) Assays of RSV binding at 4°C for 1 hour followed by quantification of relative RSV L gene levels by RT-qPCR. (I) Assays of primary RSV transcript and genome replication after infection at 37°C for 6 hours by RT-qPCR. (J) Assays of JNJ-678 (100 nM) treatment at 6 hpi followed by quantification of relative RSV L gene levels by RT-qPCR at 2 dpi. Each dot represents 1 donor. Bar graphs represent mean ± SEM. Statistical significance was calculated by 2-way ANOVA followed by Dunn’s test in G and by 2-tailed Student’s t test in H–J. Dotted lines mark basement membrane. **P < 0.01, ***P < 0.001. Scale bars: 50 μm.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts